| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/07/2011 | WO2011041634A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | WO2011041542A2 Herbal pain killer compositions |
| 04/07/2011 | WO2011041483A2 Use of botulinum neurotoxin to treat substance addictions |
| 04/07/2011 | WO2011041451A2 Smoking cessation with body weight maintenance and nutritional supplement |
| 04/07/2011 | WO2011041293A1 Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
| 04/07/2011 | WO2011041198A1 Substituted imidazole derivatives for treatment of alzheimers disease |
| 04/07/2011 | WO2011040697A1 Food composition containing concentrate of theanine and oat extract for promoting memory, learning ability and psychological stability |
| 04/07/2011 | WO2011040342A1 Agent for inhibiting decrease of visceral fat in patient with parkinson's disease |
| 04/07/2011 | WO2011040004A1 Novel phenylpyridine derivative and medicinal agent comprising same |
| 04/07/2011 | WO2011039746A1 Amide derivatives of valproic acid and uses thereof |
| 04/07/2011 | WO2011039381A1 Antioxidants for use in therapy |
| 04/07/2011 | WO2011038662A1 Compounds as trpv1 blockers, pharmaceutical compositions and medical uses thereof |
| 04/07/2011 | WO2011038574A1 Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders |
| 04/07/2011 | WO2011038572A1 Novel compounds |
| 04/07/2011 | WO2011038451A1 Therapy and prevention of problem drinking |
| 04/07/2011 | WO2011000945A9 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 04/07/2011 | WO2010138395A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 04/07/2011 | WO2010132609A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/07/2011 | WO2010129665A3 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis |
| 04/07/2011 | WO2010111080A3 Ly2140023 for treatment of schizophrenia in patients with variants of htr2a, nrgl, drd2, drd3, comt, grm3 and pkhdl genes |
| 04/07/2011 | WO2010088455A3 Cromolyn derivatives and related methods of imaging and treatment |
| 04/07/2011 | WO2010008776A3 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 04/07/2011 | US20110082482 Materials and Methods for Nerve Repair |
| 04/07/2011 | US20110082407 Combination Therapies for the Treatment of Obesity |
| 04/07/2011 | US20110082213 Novel salts of o-desmethyl-venlafaxine |
| 04/07/2011 | US20110082211 Method for treating tinnitus aureum |
| 04/07/2011 | US20110082209 Novel Salts of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082203 Process to diagnose or treat brain injury |
| 04/07/2011 | US20110082198 Theaflavin compositions, production, and methods to control physiological disorders in mammals |
| 04/07/2011 | US20110082196 Theaflavin compositions, related processes and methods of use |
| 04/07/2011 | US20110082192 Lipoic acid acylated salicylate derivatives and their uses |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082187 Markers and methods relating to the assessment of alzheimer's disease |
| 04/07/2011 | US20110082183 Phenyl pyrrole aminoguanidine derivatives |
| 04/07/2011 | US20110082178 Methods of treating autoimmune and inflammatory diseases and disorders |
| 04/07/2011 | US20110082173 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
| 04/07/2011 | US20110082166 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/07/2011 | US20110082157 Piperidinylamino-Thieno [2,3-D] Pyrimidine Compounds |
| 04/07/2011 | US20110082154 Sigma ligands for neuronal regeneration and functional recovery |
| 04/07/2011 | US20110082153 Gamma secretase modulators |
| 04/07/2011 | US20110082152 Therapeutic agents useful for treating pain |
| 04/07/2011 | US20110082151 Sulfonylurea modulators of endothelin receptor |
| 04/07/2011 | US20110082150 Headache pre-emption by dihydroergotamine treatment during headache Precursor events |
| 04/07/2011 | US20110082147 Substituted imidazotriazines |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082141 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 04/07/2011 | US20110082137 New compounds for the treatment of cns disorders |
| 04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 04/07/2011 | US20110082129 Organic compounds |
| 04/07/2011 | US20110082117 Phenyl sulfonamides as modulators of ion channels |
| 04/07/2011 | US20110082109 Novel acyl guanidine derivatives |
| 04/07/2011 | US20110082107 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110081421 Methods of regulating renalase (monoamine oxidase c) |
| 04/07/2011 | US20110081385 Compositions and Methods for Sleep Regulation |
| 04/07/2011 | US20110081364 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 04/07/2011 | US20110081355 Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies |
| 04/07/2011 | US20110081340 Methods for treating disease using an anti-il-21 receptor antibody |
| 04/07/2011 | US20110081338 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110081329 Amino acid compositions |
| 04/07/2011 | US20110081323 Methods and compositions for organ and tissue functionality |
| 04/07/2011 | US20110081320 Treatment/Cure of Autoimmune Disease |
| 04/07/2011 | US20110081316 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | US20110081297 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles |
| 04/07/2011 | DE102009042459A1 Composition, useful for the treatment and prophylaxis of diseases of the liver, cardiovascular disease, dementia and Alzheimer's disease, comprises colloidal silver, gold and/or platinum and a choline-containing phosphoglyceride |
| 04/07/2011 | CA2776160A1 Smoking cessation with body weight maintenance and nutritional supplement |
| 04/07/2011 | CA2775753A1 Novel compounds |
| 04/07/2011 | CA2772797A1 Substituted imidazole derivatives for treatment of alzheimers disease |
| 04/06/2011 | EP2305823A1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305709A1 Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305682A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/06/2011 | EP2305679A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 04/06/2011 | EP2305678A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305675A1 Indazoles, Benzothiazoles, and Benzoisothiazoles, and preparation and uses thereof |
| 04/06/2011 | EP2305672A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY |
| 04/06/2011 | EP2305669A1 Amine compounds and their pharmaceutical use |
| 04/06/2011 | EP2305664A1 Anabaseine derivatives useful in the treatment of neurodegeneratives diseases |
| 04/06/2011 | EP2305656A1 Optical isomers of an iloperidone metabolite |
| 04/06/2011 | EP2305654A1 Therapeutic agent for pain |
| 04/06/2011 | EP2305651A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/06/2011 | EP2305645A1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 04/06/2011 | EP2305644A1 Aralkyl alcohol piperidine derivative and the use as medicament for treating depression thereof |
| 04/06/2011 | EP2305633A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 04/06/2011 | EP2305629A1 Therapeutic agent for alzheimer's disease |
| 04/06/2011 | EP2305353A1 Augmented cognitive training |
| 04/06/2011 | EP2305308A1 Remedies for diseases to be applied to eye |
| 04/06/2011 | EP2305306A1 Neuroinvasion inhibitor |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305302A2 Prevention and treatment of amyloidogenic disease |